Piramal Pharma Ltd. · Q3FY25
Result on 28 Jan 2025, first traded on 29 Jan 2025; judged on 13 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →
unreadverdict
—the read
-8.8%vs market, 10 sessions
+5.8%T+1
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹218.55the base every move below is measured from
T+1+5.8%
T+10-8.4%market +0.4% · sector +1.7%
vs market-8.8%vs sector -10.0%
Best close after+9.5%traded as high as +12.1% on 29 Jan
Worst close after-8.4%traded as low as -10.7% on 12 Feb
Run-up, 30 sessions-13.0%into the result
52-week range26% below high89% above low
- Delivery share
- -2.9 points in the fortnight before, against the month before that
- Volume
- 0.47× its prior month, in the fortnight before
- Habit held
- unknown — could not be checked
- Announced
- Wed, after the close — the reaction session is the next day
- Peers reporting
- 4 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- 4 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-29 | 17 Dec | 257.05 | 272.00 | 256.05 | 260.60 | — | +19.24% | +6.01% | +6.14% |
| T-28 | 18 Dec | 262.00 | 270.00 | 256.75 | 264.70 | +1.57% | +21.12% | +5.41% | +7.30% |
| T-27 | 19 Dec | 259.80 | 264.80 | 256.60 | 261.60 | -1.17% | +19.70% | +4.33% | +9.14% |
| T-26 | 20 Dec | 264.40 | 268.80 | 249.70 | 252.20 | -3.59% | +15.40% | +2.75% | +8.20% |
| T-25 | 23 Dec | 253.95 | 257.40 | 252.45 | 255.40 | +1.27% | +16.86% | +3.47% | +8.54% |
| T-24 | 24 Dec | 256.15 | 257.40 | 250.65 | 255.00 | -0.16% | +16.68% | +3.36% | +8.47% |
| T-23 | 26 Dec | 255.90 | 260.80 | 252.25 | 257.35 | +0.92% | +17.75% | +3.45% | +9.21% |
| T-22 | 27 Dec | 255.05 | 257.35 | 253.85 | 254.55 | -1.09% | +16.47% | +3.73% | +10.64% |
| T-21 | 30 Dec | 254.60 | 269.75 | 248.35 | 265.30 | +4.22% | +21.39% | +3.00% | +11.75% |
| T-20 | 31 Dec | 264.00 | 273.35 | 259.25 | 266.25 | +0.36% | +21.83% | +2.99% | +12.58% |
| T-19 | 1 Jan | 265.00 | 267.65 | 256.50 | 258.25 | -3.00% | +18.17% | +3.42% | +12.81% |
| T-18 | 2 Jan | 260.00 | 262.70 | 253.00 | 257.30 | -0.37% | +17.73% | +5.36% | +13.26% |
| T-17 | 3 Jan | 257.90 | 260.80 | 254.05 | 254.85 | -0.95% | +16.61% | +4.56% | +11.86% |
| T-16 | 6 Jan | 255.00 | 255.65 | 244.20 | 247.65 | -2.83% | +13.32% | +2.87% | +10.95% |
| T-15 | 7 Jan | 248.10 | 253.35 | 248.10 | 250.50 | +1.15% | +14.62% | +3.27% | +11.69% |
| T-14 | 8 Jan | 252.00 | 252.50 | 245.00 | 245.70 | -1.92% | +12.42% | +3.19% | +10.65% |
| T-13 | 9 Jan | 245.55 | 251.15 | 233.30 | 237.15 | -3.48% | +8.51% | +2.48% | +9.96% |
| T-12 | 10 Jan | 237.15 | 238.95 | 218.00 | 221.25 | -6.70% | +1.24% | +2.07% | +7.62% |
| T-11 | 13 Jan | 215.05 | 242.50 | 215.00 | 232.65 | +5.15% | +6.45% | +0.56% | +5.32% |
| T-10 | 14 Jan | 236.95 | 241.10 | 224.50 | 234.95 | +0.99% | +7.50% | +0.95% | +6.77% |
| T-9 | 15 Jan | 236.90 | 237.45 | 229.25 | 230.70 | -1.81% | +5.56% | +1.11% | +5.66% |
| T-8 | 16 Jan | 233.90 | 236.90 | 232.75 | 234.40 | +1.60% | +7.25% | +1.54% | +5.35% |
| T-7 | 17 Jan | 233.95 | 234.00 | 228.80 | 230.70 | -1.58% | +5.56% | +1.07% | +6.08% |
| T-6 | 20 Jan | 232.05 | 244.45 | 229.40 | 242.05 | +4.92% | +10.75% | +1.69% | +6.66% |
| T-5 | 21 Jan | 242.05 | 247.10 | 238.00 | 240.90 | -0.48% | +10.23% | +0.29% | +5.22% |
| T-4 | 22 Jan | 241.60 | 244.15 | 236.65 | 242.30 | +0.58% | +10.87% | +0.86% | +5.95% |
| T-3 | 23 Jan | 242.30 | 251.95 | 238.60 | 239.70 | -1.07% | +9.68% | +1.08% | +7.44% |
| T-2 | 24 Jan | 239.70 | 240.45 | 230.35 | 233.05 | -2.77% | +6.63% | +0.59% | +5.17% |
| T-1 | 27 Jan | 232.05 | 233.60 | 221.90 | 223.90 | -3.93% | +2.45% | -0.56% | +2.38% |
| base | 28 Jan | 226.45 | 227.15 | 211.30 | 218.55 | -2.39% | +0.00% | +0.00% | +0.00% |
| T+1 | 29 Jan result | 205.25 | 245.00 | 205.25 | 239.30 | +9.49% | +9.49% | +0.90% | +1.77% |
| T+2 | 30 Jan | 236.45 | 241.35 | 229.75 | 231.25 | -3.36% | +5.81% | +1.27% | +3.00% |
| T+3 | 31 Jan | 231.20 | 238.95 | 231.00 | 232.90 | +0.71% | +6.57% | +2.40% | +3.09% |
| T+4 | 3 Feb | 228.00 | 235.99 | 225.88 | 231.67 | -0.53% | +6.00% | +1.76% | +2.72% |
| T+5 | 4 Feb | 233.00 | 235.00 | 225.15 | 227.02 | -2.01% | +3.88% | +3.41% | +4.51% |
| T+6 | 5 Feb | 229.11 | 237.48 | 228.30 | 230.53 | +1.55% | +5.48% | +3.22% | +5.15% |
| T+7 | 6 Feb | 232.00 | 233.29 | 226.90 | 229.76 | -0.33% | +5.13% | +2.81% | +5.83% |
| T+8 | 7 Feb | 230.40 | 233.00 | 224.01 | 226.46 | -1.44% | +3.62% | +2.63% | +6.16% |
| T+9 | 10 Feb | 228.00 | 228.01 | 219.05 | 221.24 | -2.31% | +1.23% | +1.85% | +4.18% |
| T+10 | 11 Feb | 220.80 | 221.30 | 203.00 | 204.28 | -7.67% | -6.53% | +0.50% | +2.18% |
| T+11 | 12 Feb | 204.00 | 204.79 | 195.21 | 200.25 | -1.97% | -8.37% | +0.38% | +1.66% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.